Gaoxin Branch, Jinan Stomatological Hospital, Jinan, Shandong Province, China.
PLoS One. 2024 May 2;19(5):e0302581. doi: 10.1371/journal.pone.0302581. eCollection 2024.
We will perform the systematic review to evaluate the effect of applying concentrated growth factor (CGF) on relieving postoperative complications and promoting wound healing following mandibular third molar extraction.
The PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Database, China Biology Medicine Disc (CBM), and VIP Databases will be comprehensively searched up to May 31, 2024. Randomized controlled trials (RCTs) examining the application of CGF after mandibular third molar extraction will be included. The protocol was registered in PROSPERO, and the registration ID was CRD42023463234. Two reviewers will conduct the literature search, eligible study selection, data extraction, and bias risk assessment (using the Cochrane Risk of Bias 2.0 tool). Data analysis will be performed with RevMan software (version 5.4).
The results of this study will be available in a peer-reviewed journal.
Our study will provide scientific evidence regarding the efficacy of applying CGF in mandibular third molar extraction.
我们将进行系统评价,评估浓缩生长因子(CGF)在缓解下颌第三磨牙拔除术后并发症和促进伤口愈合方面的效果。
全面检索 PubMed、Web of Science、Embase、Cochrane 图书馆、中国知网(CNKI)、万方数据库、中国生物医学文献数据库(CBM)和维普数据库,检索时限截至 2024 年 5 月 31 日。纳入研究下颌第三磨牙拔除后应用 CGF 的随机对照试验(RCT)。本研究方案已在 PROSPERO 注册,注册号为 CRD42023463234。由 2 名评价者独立进行文献检索、纳入研究筛选、资料提取和偏倚风险评估(使用 Cochrane 偏倚风险 2.0 工具)。采用 RevMan 软件(版本 5.4)进行数据分析。
本研究结果将发表在同行评议期刊上。
本研究将为下颌第三磨牙拔除中应用 CGF 的疗效提供科学证据。